Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q4 2015 call → NOWe need to determine if the transcript describes an offering/initiative where customer response is ahead of what the company prepared for, and the company is responding by putting more behind it. The offering must be small relative to total business. Scanning the transcript: Management discusses various projects. Key points: In Oklahoma, they brought on additional 100 MMcf at Cana plant to support Devon's production, and had record volumes in November through January. But that's about existing operations. They mention Lobo II plant in Delaware Basin, with an anchor customer, scheduled to come online in Q4. That's future. They mention Riptide plant coming online first half. Not ahead of plan. They mention "we have stable cash flows from fee-based contracts with minimum volume commitments" - not specific. They mention "we are focused on executing on growth in our core areas" - not specific. They mention "we have identified several core strategies" - not specific. They mention "we brought on an additional 100-million cubic feet of gas in a two-week period at our Cana plant to support Devon's production. This region was then impacted by severe weather and our Cana facility was one of only a few plants operating during this challenging time. We had record volumes in November through January due to the hard work of this team, the flexibility of our operations and our ability to operate when our competitors were not." This suggests that the Cana plant saw higher volumes than expected? But it's not clear if that's a new offering or just existing operations. Also, they don't mention expanding capacity in response. They mention "we are focused on executing on opportunities we see in this region as producers remain active despite current commodity prices. We expect to spend approximately $120 million to $140 million of growth capital in Texas, the majority of which will be spent in the Permian Basin. This includes the completion of two processing plant that will add 220 Mmcf per day of capacity in the Midland and Delaware Basin. The 100 million a day Riptide plant in the Midland Basin is scheduled to come online in the first half of this year. We recently began construction in Lobo II plant in the Delaware Basin which will utilize equipment we already have in inventory.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).